Delivery Order SPE2DB25D3021-SPE2DB25FQYQL
- Not listed
- The Defense Logistics Agency awarded a $4,996.66 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Janumet 50-1,000 mg tablets (60-count packages). This contract, which is not set-aside and competitively awarded, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania—which is also the place of...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Janumet 50-1,000 mg tablets in quantities of 1,000 units, with a ceiling value of $2,012.06. This is a firm fixed price delivery order with an ultimate completion date of August 12, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units) under a firm fixed-price contract valued at $13,839.99. The delivery order is non-set-aside and competitively awarded, with an ultimate completion date of August 21, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Janumet 50-1,000 mg tablets (180 count) with a contract ceiling value of $4,393.68. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for ultimate completion on July 23, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $2,239.56 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count). This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 30, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among qualified vendors. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Janumet 50-1,000 mg tablets in a quantity of 180 units, with a ceiling value of $4,327.00. This is a firm fixed-price delivery order with an ultimate completion date of August 13, 2025, and represents a competitively awarded contract with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Janumet 50-1,000 mg tablets (180 count) with a ceiling value of $14,237.99. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. The contract represents a single delivery order placed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of 180 tablets of Janumet 50-1,000 mg, a combination medication used in diabetes management. This firm fixed-price delivery order, valued at $19,727.92, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical supply vehicle running through December 2026. The award was...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,610.07 to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 17, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency issued a delivery order valued at $3,336.76 to AmerisourceBergen Drug Corp for 180 tablets of Janumet 50-1,000 mg on June 2, 2025, with an ultimate completion date of June 3, 2025. This competitively awarded, firm fixed-price delivery order was placed under no set-aside designation and will be performed at the vendor's Conshohocken, Pennsylvania location. Janumet is a combination medication used to treat type 2 diabetes, consistent with AmerisourceBergen's...
- SPE2DB25D3021Indefinite Delivery Contract
- SPE2DB25D3021-SPE2DB25FQYQLDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units) under a firm fixed-price contract with a ceiling value of $4,174.60. This non-set-aside competitive award is a child delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, with the contract's ultimate completion date set for June 17, 2025. This delivery order exemplifies AmerisourceBergen's role as a critical pharmaceutical vendor within the federal medical supply chain, supplying medications to support military healthcare and other government health systems. Janumet, a combination medication for type 2 diabetes management, falls within the company's extensive pharmaceutical portfolio that includes specialty medications, brand-name and generic drugs, and medical supplies. As a major pharmaceutical distributor, AmerisourceBergen has demonstrated consistent capability to meet federal procurement requirements through competitive awards, positioning it as a key vendor for DLA medical procurement operations serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 6/16/25 |